USD 1.75
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 100 Thousand USD | 140.01% |
2022 | 41.66 Thousand USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | -100.0% |
2015 | 33 Thousand USD | -31.25% |
2014 | 48 Thousand USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 25 Thousand USD | 0.0% |
2024 Q2 | 25 Thousand USD | 0.0% |
2024 Q3 | - USD | -100.0% |
2023 Q2 | 25 Thousand USD | -0.0% |
2023 Q3 | 25 Thousand USD | 0.0% |
2023 Q4 | 25 Thousand USD | 0.0% |
2023 FY | 100 Thousand USD | 140.01% |
2023 Q1 | 25 Thousand USD | 0.01% |
2022 Q3 | 16.66 Thousand USD | 0.0% |
2022 FY | 41.66 Thousand USD | 0.0% |
2022 Q4 | 24.99 Thousand USD | 49.99% |
2022 Q2 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q1 | - USD | -100.0% |
2018 Q4 | - USD | 0.0% |
2017 Q1 | - USD | 100.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | 13.5 Thousand USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2016 Q3 | 4500.00 USD | 0.0% |
2016 Q1 | 4500.00 USD | 115.79% |
2016 Q2 | 4500.00 USD | 0.0% |
2016 FY | - USD | -100.0% |
2016 Q4 | -13.5 Thousand USD | -400.0% |
2015 Q4 | -28.5 Thousand USD | -733.33% |
2015 FY | 33 Thousand USD | -31.25% |
2015 Q3 | 4500.00 USD | -62.5% |
2015 Q2 | 12 Thousand USD | 0.0% |
2015 Q1 | 12 Thousand USD | 0.0% |
2014 FY | 48 Thousand USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
American Oncology Network, Inc. | 1.27 Billion USD | 99.992% |
ATI Physical Therapy, Inc. | 699.01 Million USD | 99.986% |
Assure Holdings Corp. | 255 Thousand USD | 60.784% |
Novo Integrated Sciences, Inc. | 12.57 Million USD | 99.205% |